Lifeline Biotechnologies Inc (LLBO)

[GetSeriousOK]

LLBO owns 30% of the COMMON stock in Cyrcadia. LLBO gets no revenue royalties.

the Preferred Cyrcadia stock owners get the lion's share of any Cyrcadia perceived value IF Cyrcadia ever finishes clinical trials, submits something to the FDA, gets it cleared/approved, and sells the device. Five years down the road -- optimistically? The completed about half of their clinical trials in four years before the pandemic, so it will take another four years to complete AFTER the pandemic.

True current valuation of LLBO is less than .0001 per share as I posted yesterday, based on the FACTS in the balance sheet instead of conjecture about future Cyrcadian success. Luckily, it can't go lower than .0001.